@article{kim_nanomedicine_2010,
	title = {Nanomedicine},
	volume = {363},
	issn = {0028-4793},
	url = {https://doi.org/10.1056/NEJMra0912273},
	doi = {10.1056/NEJMra0912273},
	abstract = {Many diseases originate from alterations in biologic processes at the molecular or nanoscale level. Mutated genes, misfolded proteins, and infections caused by viruses or bacteria can lead to cell malfunction or miscommunication, sometimes leading to life-threatening diseases. These molecules and infectious agents are nanometers in size and may be located in biologic systems that are protected by nanometer-size barriers, such as nuclear pores 9 nm in diameter. Their chemical properties, size, and shape appear to dictate the transport of molecules to specific biologic compartments and the interactions between molecules. Nanotechnology is defined as the “intentional design, characterization, production, and applications . . .},
	number = {25},
	urldate = {2021-11-06},
	journal = {New England Journal of Medicine},
	author = {Kim, Betty Y.S. and Rutka, James T. and Chan, Warren C.W.},
	month = dec,
	year = {2010},
	pmid = {21158659},
	note = {Publisher: Massachusetts Medical Society
\_eprint: https://doi.org/10.1056/NEJMra0912273},
	pages = {2434--2443},
	file = {Full Text:files/2137/Kim et al. - 2010 - Nanomedicine.pdf:application/pdf;Snapshot:files/2142/nejmra0912273.html:text/html},
	url_Paper = {https://inbs.med.utoronto.ca/wp-content/uploads/2020/08/nejmra0912273.pdf}
}

{"_id":"YA2XB5RhNNwzaYimi","bibbaseid":"kim-rutka-chan-nanomedicine-2010","author_short":["Kim, B. Y.","Rutka, J. T.","Chan, W. C."],"bibdata":{"bibtype":"article","type":"article","title":"Nanomedicine","volume":"363","issn":"0028-4793","url":"https://doi.org/10.1056/NEJMra0912273","doi":"10.1056/NEJMra0912273","abstract":"Many diseases originate from alterations in biologic processes at the molecular or nanoscale level. Mutated genes, misfolded proteins, and infections caused by viruses or bacteria can lead to cell malfunction or miscommunication, sometimes leading to life-threatening diseases. These molecules and infectious agents are nanometers in size and may be located in biologic systems that are protected by nanometer-size barriers, such as nuclear pores 9 nm in diameter. Their chemical properties, size, and shape appear to dictate the transport of molecules to specific biologic compartments and the interactions between molecules. Nanotechnology is defined as the “intentional design, characterization, production, and applications . . .","number":"25","urldate":"2021-11-06","journal":"New England Journal of Medicine","author":[{"propositions":[],"lastnames":["Kim"],"firstnames":["Betty","Y.S."],"suffixes":[]},{"propositions":[],"lastnames":["Rutka"],"firstnames":["James","T."],"suffixes":[]},{"propositions":[],"lastnames":["Chan"],"firstnames":["Warren","C.W."],"suffixes":[]}],"month":"December","year":"2010","pmid":"21158659","note":"Publisher: Massachusetts Medical Society _eprint: https://doi.org/10.1056/NEJMra0912273","pages":"2434–2443","file":"Full Text:files/2137/Kim et al. - 2010 - Nanomedicine.pdf:application/pdf;Snapshot:files/2142/nejmra0912273.html:text/html","url_paper":"https://inbs.med.utoronto.ca/wp-content/uploads/2020/08/nejmra0912273.pdf","bibtex":"@article{kim_nanomedicine_2010,\n\ttitle = {Nanomedicine},\n\tvolume = {363},\n\tissn = {0028-4793},\n\turl = {https://doi.org/10.1056/NEJMra0912273},\n\tdoi = {10.1056/NEJMra0912273},\n\tabstract = {Many diseases originate from alterations in biologic processes at the molecular or nanoscale level. Mutated genes, misfolded proteins, and infections caused by viruses or bacteria can lead to cell malfunction or miscommunication, sometimes leading to life-threatening diseases. These molecules and infectious agents are nanometers in size and may be located in biologic systems that are protected by nanometer-size barriers, such as nuclear pores 9 nm in diameter. Their chemical properties, size, and shape appear to dictate the transport of molecules to specific biologic compartments and the interactions between molecules. Nanotechnology is defined as the “intentional design, characterization, production, and applications . . .},\n\tnumber = {25},\n\turldate = {2021-11-06},\n\tjournal = {New England Journal of Medicine},\n\tauthor = {Kim, Betty Y.S. and Rutka, James T. and Chan, Warren C.W.},\n\tmonth = dec,\n\tyear = {2010},\n\tpmid = {21158659},\n\tnote = {Publisher: Massachusetts Medical Society\n\\_eprint: https://doi.org/10.1056/NEJMra0912273},\n\tpages = {2434--2443},\n\tfile = {Full Text:files/2137/Kim et al. - 2010 - Nanomedicine.pdf:application/pdf;Snapshot:files/2142/nejmra0912273.html:text/html},\n\turl_Paper = {https://inbs.med.utoronto.ca/wp-content/uploads/2020/08/nejmra0912273.pdf}\n}\n\n","author_short":["Kim, B. Y.","Rutka, J. T.","Chan, W. C."],"key":"kim_nanomedicine_2010","id":"kim_nanomedicine_2010","bibbaseid":"kim-rutka-chan-nanomedicine-2010","role":"author","urls":{"Paper":"https://doi.org/10.1056/NEJMra0912273"," paper":"https://inbs.med.utoronto.ca/wp-content/uploads/2020/08/nejmra0912273.pdf"},"metadata":{"authorlinks":{}},"downloads":2,"html":""},"bibtype":"article","biburl":"https://inbslab.com//wp-content/uploads/2024/03/Chan-2024_03-14.txt","dataSources":["zb3p4i4Fd9wXynbkF","pF7M3AvRzd8m3Nc5t","BqtRhZTYdfYNLhWzp","sBWiDMMhfDHZnN93b","zkBeHFgTXc62hytzj","s3xwaPmQ7EjjEcMSb","5npqWkz6DHBZLyn3J","yc5dXnBwovT8YvCrt","nLduyq7S9B96QB8B5","JiWrSgLBTKbDLqiYi"],"keywords":[],"search_terms":["nanomedicine","kim","rutka","chan"],"title":"Nanomedicine","year":2010,"downloads":2}